Although the hyperactivation of IRE1-induced renal inflammation and fibrosis were found, the therapeutic effect of the IRE1 RNase targeted molecule, XBP1s, was proved by Lian Qiu et al. in a mouse model of ulcerative colitis (UC) or inflammatory bowel disease (IBD). This evidence concerns the gene ERN1 and ulcerative colitis.